ASC Therapeutics focuses on the development of curative therapies for rare diseases. Our gene, CRISPR and cell therapies were developed at Applied StemCell, a life sciences company for over 12 years, including proprietary gene editing technologies. Our development pipeline includes several preclinical stage projects focusing on monogenic blood disorders that exhibit a high genetic penetrance and conditions requiring immunomodulatory interventions. Contact us for partnership opportunities. #therapeutics #CRISPR #celltherapy #genetherapy #blooddisorders #hemophilia www.asctherapeutics.com
Company Details
- Employees
- 20
- Founded
- 2008
- Address
- 521 Cottonwood Drive Suite 111, Milpitas,ca 95035,united States
- Industry
- Biotechnology
- Website
- asctherapeutics.com
- Keywords
- Clinical, Biologics, AAV, Cell Therapy, Gene Therapy, Biotech, Therapeutic, Genome Editing, Blood disease, Genetic disease, CRISPR, Phase I study, Gene Replacement, Stem Cells, Biotech Venture, Start up, Phase II, Drug development.
- HQ
- Milpitas, CA
Asc Therapeutics Questions
Asc Therapeutics's website is asctherapeutics.com
Asc Therapeutics's LinkedIn profile is https://www.linkedin.com/company/asc-therapeutics
Asc Therapeutics has
20 employees.
View email and phone details for 20
employees at Asc Therapeutics.
Asc Therapeutics's industry is
Biotechnology
Asc Therapeutics's top competitors are
Thrive Bioscience, Inc.,
Applied Stem Cell Technologies (Ast),
Guardant Health,
Sonothera,
Genentech,
Humancells Biosciences,
Applied Stemcell,
Laboratory For Genomics Research,
Beam Therapeutics,
Xuanzhu Biopharmaceutical Co., Ltd..
Asc Therapeutics's categories are Biotechnology
Asc Therapeutics's founding year is 2008
